Patent ID: 8729080
Filing Date: 2014-05-20
Classification: A61K,A61P

Abstract:
1. A method for the treatment of cancer in a subject, said method comprising administering to said subject a therapeutically effective amount of a compound selected from the group consisting of N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide (PJ-34), 6-(5H)-phenanthridinone (Phen) and pharmaceutically acceptable salts thereof, wherein said therapeutically effective amount of said compound is about 15-25 mg per kg body weight per day and has a lethal effect on cells of said cancer, and wherein said cancer is selected from the group consisting of breast cancer, colon cancer, lung cancer, pancreatic cancer, ovarian cancer, glioblastoma and leukemia.